De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

PetIQ Inkomsten in het verleden

Verleden criteriumcontroles 2/6

PetIQ is de winst gegroeid met een gemiddeld jaarlijks percentage van 15.7%, terwijl de Healthcare industrie de winst jaarlijks groeide met 6.2%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 10.4% per jaar. Het rendement op eigen vermogen van PetIQ is 5.3%, en het heeft een nettomarge van 1.2%.

Belangrijke informatie

15.7%

Groei van de winst

18.4%

Groei van de winst per aandeel

Healthcare Groei van de industrie	8.5%
Inkomstengroei	10.4%
Rendement op eigen vermogen	5.3%
Nettomarge	1.2%
Laatste winstupdate	30 Jun 2024

Recente prestatie-updates uit het verleden

Recent updates

PetIQ, Inc. (NASDAQ:PETQ) Stock Rockets 26% But Many Are Still Ignoring The Company

Aug 16

PetIQ (NASDAQ:PETQ) Has A Somewhat Strained Balance Sheet

Aug 10

PetIQ's (NASDAQ:PETQ) Returns On Capital Are Heading Higher

Jun 14

PetIQ (NASDAQ:PETQ) May Have Issues Allocating Its Capital

Feb 11

PetIQ gains 1.84 % on $30M stock repurchase program

Sep 06

PetIQ (NASDAQ:PETQ) Use Of Debt Could Be Considered Risky

Aug 23

Here's What's Concerning About PetIQ's (NASDAQ:PETQ) Returns On Capital

Jul 27

Is PetIQ (NASDAQ:PETQ) Using Too Much Debt?

May 06

There Are Reasons To Feel Uneasy About PetIQ's (NASDAQ:PETQ) Returns On Capital

Apr 02

The Prognosis For PetIQ

Feb 12

PetIQ: Economies Of Scale Will Kick In Eventually

Jan 03

PetIQ, Trupanion: Pet Care Industry Small Players Still Not Cheap Enough

Sep 09

Why We Think PetIQ, Inc.'s (NASDAQ:PETQ) CEO Compensation Is Not Excessive At All

Jun 23

Opbrengsten en kosten

Hoe PetIQ geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

NasdaqGS:PETQ Opbrengsten, kosten en inkomsten (USD Millions )
Datum	Inkomsten	Inkomsten	G+A Uitgaven	R&D-uitgaven
30 Jun 24	1,134	13	202	1
31 Mar 24	1,120	7	197	1
31 Dec 23	1,102	2	190	1
30 Sep 23	1,066	13	186	2
30 Jun 23	999	-37	177	2
31 Mar 23	936	-42	172	2
31 Dec 22	922	-48	174	2
30 Sep 22	934	-55	173	8
30 Jun 22	935	-14	170	8
31 Mar 22	954	-15	164	8
31 Dec 21	933	-16	158	8
30 Sep 21	900	-11	136	0
30 Jun 21	852	-73	138	0
31 Mar 21	848	-79	122	1
31 Dec 20	780	-83	116	2
30 Sep 20	770	-85	121	3
30 Jun 20	794	-20	102	3
31 Mar 20	748	-15	95	2
31 Dec 19	709	-11	91	1
30 Sep 19	666	-4	84	0
30 Jun 19	611	4	75	0
31 Mar 19	562	3	69	0
31 Dec 18	529	-1	67	0
30 Sep 18	470	-1	60	0
30 Jun 18	399	-3	53	0
31 Mar 18	315	-6	49	0
31 Dec 17	267	-3	37	1
30 Sep 17	260	0	34	0
30 Jun 17	241	0	32	0
31 Mar 17	215	-2	29	0
31 Dec 16	200	0	28	0
31 Mar 16	202	-5	33	0
31 Dec 15	206	0	35	0
31 Dec 14	161	-11	29	1

Kwaliteitswinsten: PETQ heeft een grote eenmalige verlies van $19.8M wat gevolgen heeft voor de financiële resultaten van de laatste 12 maanden tot 30th June, 2024.

Groeiende winstmarge: PETQ is in het verleden winstgevend geweest.

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: PETQ is de afgelopen 5 jaar winstgevend geworden en heeft de winst met 15.7% per jaar laten groeien.

Versnelling van de groei: PETQ is het afgelopen jaar winstgevend geworden, waardoor de winstgroei moeilijk te vergelijken is met het 5-jarig gemiddelde.

Winst versus industrie: PETQ is het afgelopen jaar winstgevend geworden, waardoor het lastig is om de winstgroei van het afgelopen jaar te vergelijken met die van de Healthcare -sector ( 8% ).

Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 5.3% ) van PETQ wordt als laag beschouwd.

PetIQ Inkomsten in het verleden

Verleden criteriumcontroles 2/6

Belangrijke informatie

Recente prestatie-updates uit het verleden

Second quarter 2024 earnings released: EPS: US$0.52 (vs US$0.33 in 2Q 2023)

PetIQ, Inc. to Report Q2, 2024 Results on Aug 07, 2024

First quarter 2024 earnings released: EPS: US$0.51 (vs US$0.33 in 1Q 2023)

PetIQ, Inc. to Report Q1, 2024 Results on May 08, 2024

Full year 2023 earnings released: EPS: US$0.073 (vs US$1.65 loss in FY 2022)

PetIQ, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Recent updates

Does PetIQ (NASDAQ:PETQ) Have A Healthy Balance Sheet?

PetIQ: Attractive Acquisition Offer After Strong Earnings Growth In Q2

Second quarter 2024 earnings released: EPS: US$0.52 (vs US$0.33 in 2Q 2023)

New minor risk - Share price stability

Bansk Group LLC entered into an Agreement and Plan of Merger to acquire PetIQ, Inc. (NasdaqGS:PETQ) for approximately $980 million.

Price target increased by 8.3% to US$30.33

Bansk Group LLC entered into an Agreement and Plan of Merger to acquire PetIQ, Inc. (NasdaqGS:PETQ) for approximately $980 million.

President & COO exercised options and sold US$483k worth of stock

PetIQ, Inc. to Report Q2, 2024 Results on Aug 07, 2024

PetIQ: Product Margin Gains Offset By Higher Marketing Spend

Insider exercised options and sold US$89k worth of stock

Independent Director recently sold US$269k worth of stock

PetIQ, Inc. Provides Earnings Guidance for the Second Quarter of 2024 and Revised Earnings Guidance for the Full Year 2024

First quarter 2024 earnings released: EPS: US$0.51 (vs US$0.33 in 1Q 2023)

PetIQ, Inc. to Report Q1, 2024 Results on May 08, 2024

PetIQ, Inc., Annual General Meeting, Jun 07, 2024

White Brook Capital - PetIQ: Guidance And Street Estimates Are Too Conservative

PetIQ (NASDAQ:PETQ) Seems To Use Debt Quite Sensibly

PetIQ, Inc. Announces Expansion of Minties Dental Treats Brand with Launch of New Dental Chew for Large-Sized Dogs

Chairman of the Board & CEO exercised options and sold US$362k worth of stock

Full year 2023 earnings released: EPS: US$0.073 (vs US$1.65 loss in FY 2022)

Petiq, Inc. Provides Sales Guidance for the First Quarter and Full Year of 2024

Chairman of the Board & CEO exercised options and sold US$154k worth of stock

PetIQ, Inc. to Report Q4, 2023 Results on Feb 28, 2024

PetIQ: Cost Savings, Higher EBITDA Suggest A Potential Valuation Re-Rate

Chief Financial Officer exercised options and sold US$97k worth of stock

PetIQ, Inc.'s New Sentry™? Portable Calming Diffuser Helps Calm Dogs and Cats During the Busy Holiday Season and Beyond

New major risk - Revenue and earnings growth

Third quarter 2023 earnings released: EPS: US$0.015 (vs US$1.68 loss in 3Q 2022)

Petiq, Inc. Provides Earnings Guidance for the Full Year of 2023

PetIQ, Inc. to Report Q3, 2023 Results on Nov 07, 2023

Investors Will Want PetIQ's (NASDAQ:PETQ) Growth In ROCE To Persist

PetIQ, Inc. (NASDAQ:PETQ) Stock Rockets 26% But Many Are Still Ignoring The Company

PetIQ, Inc. Revises Earnings Guidance for the Full Year 2023

PetIQ (NASDAQ:PETQ) Has A Somewhat Strained Balance Sheet

Price target increased by 13% to US$27.50

Petiq, Inc. Announces Termination of R. Michael Herrman, as Executive Vice President and Corporate Secretary

PetIQ, Inc. to Report Q2, 2023 Results on Aug 08, 2023

PetIQ's (NASDAQ:PETQ) Returns On Capital Are Heading Higher

Petiq, Inc. Provides Earnings Guidance for the Second Quarter of 2023 and Reiterates Earnings Guidance for the Full Year 2023

First quarter 2023 earnings released: EPS: US$0.33 (vs US$0.11 in 1Q 2022)

Chairman of the Board & CEO exercised options and sold US$68k worth of stock

Full year 2022 earnings released: US$1.65 loss per share (vs US$0.56 loss in FY 2021)

Price target decreased by 10% to US$21.75

PetIQ (NASDAQ:PETQ) May Have Issues Allocating Its Capital

PetIQ, Inc. to Report Q4, 2022 Results on Feb 28, 2023

Third quarter 2022 earnings released: US$1.68 loss per share (vs US$0.27 loss in 3Q 2021)

Price target decreased to US$24.25

PetIQ, Inc. to Report Q3, 2022 Results on Nov 09, 2022

President & COO recently bought US$97k worth of stock

PetIQ, Inc. (NasdaqGS:PETQ) announces an Equity Buyback for $30 million worth of its shares.

PetIQ gains 1.84 % on $30M stock repurchase program

PetIQ (NASDAQ:PETQ) Use Of Debt Could Be Considered Risky

Second quarter 2022 earnings released: EPS: US$0.16 (vs US$0.14 in 2Q 2021)

PetIQ, Inc. Provides Sales Guidance for the Third Quarter and Full Year 2022

Here's What's Concerning About PetIQ's (NASDAQ:PETQ) Returns On Capital

PetIQ, Inc. to Report Q2, 2022 Results on Aug 09, 2022

High number of new directors

PetIQ, Inc. Appoints John Pearson as Senior Vice President, Head of Services Division

Price target decreased to US$30.75

PetIQ, Inc. Announces Demise of Larry Bird

President exercised options and sold US$56k worth of stock

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Is PetIQ (NASDAQ:PETQ) Using Too Much Debt?

High number of new directors

PetIQ, Inc. Provides Revenue Guidance for the Second Quarter, First Half and Full Year 2022

PetIQ, Inc., Annual General Meeting, Jun 22, 2022

PetIQ, Inc. to Report Q1, 2022 Results on May 04, 2022

There Are Reasons To Feel Uneasy About PetIQ's (NASDAQ:PETQ) Returns On Capital